Simon Hanio

Mr. Simon Hanio

Institute for Pharmacy and Food Chemistry, University of Würzburg, Würzburg, Bavaria, Germany
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Journal of Controlled Release
Verified
Journal Article
Closed access
JSJonas Schlauersbach
Jonas Schlauersbach
Simon HanioSimon Hanio
Simon Hanio
BLBettina Lenz
Bettina Lenz
SVSahithya P.B. Vemulapalli
Sahithya P.B. Vemulapalli
CGChristian Griesinger
Christian Griesinger
LMLorenz Meinel
Lorenz Meinel

1 January 2022 in Journal of Colloid and Interface Science
Verified
Journal Article
Open access
SESebastian Endres
Sebastian Endres
EKEmil Karaev
Emil Karaev
Simon HanioSimon Hanio
Simon Hanio
JSJonas Schlauersbach
Jonas Schlauersbach
CKChristian Kraft
Christian Kraft
APAnn-Christin Poeppler
Ann-Christin Poeppler
Many drugs and drug candidates are poorly water-soluble. Intestinal fluids play an important role in their solubilization. However, the interactions of intestinal fluids with polymer excipients, drugs and their formulations are not fully understood. Here, diffusion ordered spectroscopy (DOSY) and nuclear Overhauser effect spectroscopy (NOESY), complemented by cryo-TEM were employed to address this. Efavirenz (EFV) as model drug, the triblock copolymers Pluronic® F-127 (PF127) and poly(2-oxazoline) based pMeOx-b-pPrOzi-b-pMeOx (pOx/pOzi) and their respective formulations were studied in simulated fed-state intestinal fluid (FeSSIF). For the individual polymers, the bile interfering nature of PF127 was confirmed and pure pOx/pOzi was newly classified as non-interfering. A different and more complex behaviour was however observed if EFV was involved. PF127/EFV formulations in FeSSIF showed concentration dependent aggregation with separate colloids at low formulation concentrations, a merging of individual particles at the solubility limit of EFV in FeSSIF and joint aggregates above this concentration. In the case of pOx/pOzi/EFV formulations, coincident diffusion coefficients for pOx/pOzi, lipids and EFV indicate joint aggregates across the studied concentration range. This demonstrates that separate evaluation of polymers and drugs in biorelevant media is not sufficient and their mixtures need to be studied to learn about concentration and composition dependent behaviour.

15 February 2021 in Langmuir
Verified
Journal Article
Closed access
Simon HanioSimon Hanio
Simon Hanio
JSJonas Schlauersbach
Jonas Schlauersbach
BLBettina Lenz
Bettina Lenz
FSFranziska Spiegel
Franziska Spiegel
RBRainer A Böckmann
Rainer A Böckmann
LMLorenz Meinel
Lorenz Meinel

1 July 2022 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
JSJonas Schlauersbach
Jonas Schlauersbach
JKJosef Kehrein
Josef Kehrein
Simon HanioSimon Hanio
Simon Hanio
BGBruno Galli
Bruno Galli
CHCornelius Harlacher
Cornelius Harlacher
LMLorenz Meinel
Lorenz Meinel

22 July 2020 in ACS Omega
Verified
Journal Article
Closed access
PGPaul Güntzel
Paul Güntzel
KSKlaus Schilling
Klaus Schilling
Simon HanioSimon Hanio
Simon Hanio
JSJonas Schlauersbach
Jonas Schlauersbach
CSCurd Schollmayer
Curd Schollmayer
UHUlrike Holzgrabe
Ulrike Holzgrabe

31 October 2023 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
Simon HanioSimon Hanio
Simon Hanio
SMStephanie Möllmert
Stephanie Möllmert
CMConrad Möckel
Conrad Möckel
SCSusobhan Choudhury
Susobhan Choudhury
AHAndreas I. Höpfel
Andreas I. Höpfel
LMLorenz Meinel
Lorenz Meinel